In vivo modulation of natural killer cell activity by tamoxifen in patients with bilateral primary breast cancer

Second cancer following cancer of the breast in Connecticut, 1935-82.

1985 • 308 citations

The Prognostic Significance of Natural Killer Cytotoxicity in Patients With Colorectal Cancer

1987 • 182 citations

Immunosuppression in Viral Infections

1986 • 181 citations

Natural Cytotoxicity of Peripheral Blood Lymphocytes and Regional Lymph Node Cells in Breast Cancer in Women<xref ref-type="fn" rid="fn2">2</xref><xref ref-type="fn" rid="fn3">3</xref>

1981 • 89 citations

Natural killer (NK) activity in peripheral blood lymphocytes of patients with benign and malignant breast disease

1982 • 79 citations

Adjuvant systemic therapy for early breast cancer

1987 • 75 citations

Modulation of natural killer cell activity by tamoxifen in stage I post-menopausal breast cancer

1987 • 74 citations

Human natural cytotoxicity in the blood and lymphoid organs of healthy donors and patients with malignant disease

1978 • 73 citations

Controlled trial of tamoxifen as single adjuvant agent in management of early breast cancer. Analysis at six years by Nolvadex Adjuvant Trial Organisation.

1985 • 53 citations

Relationship of human natural lymphocyte‐mediated cytotoxicity to cytotoxicity of breast‐cancer‐derived target cells

1977 • 49 citations

Analysis of T Helper and Suppressor Lymphocyte Subsets in Relation to the Clinical Stage of Solid Neoplasms

1990 • 34 citations

The relationship of clinical status and therapeutic modality to natural killer cell activity in human breast cancer

1985 • 33 citations

Influence of adjuvant tamoxifen on blood lymphocytes

1988 • 31 citations

Estradiol-Induced alteration in the immune system. II. Suppression of cellular immunity in the rat is not the result of direct estrogenic action

1986 • 28 citations

Effect of treatment on the immunological status of women with advanced breast cancer

1979 • 22 citations

Immunoglobulin secretion during the autologous mixed lymphocyte reaction in man.

1983 • 19 citations

Effect of tamoxifen on immune functions.

1986 • 18 citations

Natural killer activity in patients with breast cancer.

1990 • 17 citations

Effect on natural killer and antibody-dependent cellular cytotoxicity of adjuvant cytotoxic chemotherapy including melphalan in breast cancer

1983 • 16 citations

The effect of adjuvant cyclophosphamide or tamoxifen on the numbers of lymphocytes bearing T cell or NK cell markers

1987 • 16 citations

Classic Kaposi's sarcoma: T-lymphocyte subsets, T4/T8 ratio, and NK cell activity

1991 • 14 citations

Second primary breast cancer

1988 • 8 citations